From disease biomarkers to health monitoring, from food safety to environmental protection — we leverage Bio-FET technology to decode the subtle signals of life.
Bridging the gap between scientific research and commercial application, delivering high-quality solutions that create social value and public well-being.
Medical diagnosis is a systematic process that integrates clinical symptoms, laboratory results, and imaging data. The Bio-FET biochip, with its exceptional sensitivity and specificity, facilitates rapid, label-free detection of trace-level biomarkers — such as proteins or nucleic acids — in bodily fluids. The key strength of this technology lies in its ability to provide early warning: identifying disease indicators at the earliest stages — including cancer, osteoarthritis, or dengue fever infection — before obvious clinical symptoms appear. This significantly improves diagnostic efficiency and empowers clinicians with actionable insights needed for personalized treatment, enabling truly individualized precision medicine and meaningfully improving patient outcomes.
In food safety, contamination by harmful microorganisms — such as E. coli, Salmonella, Staphylococcus aureus, and Listeria — is a leading cause of food poisoning, gastroenteritis, and infectious disease. Because contamination is invisible to the naked eye, professional testing is essential; however, conventional methods are often time-consuming and unable to meet the demands of real-time intervention. The Bio-FET biochip offers an innovative solution combining high sensitivity with rapid detection. It can sense low-concentration pathogen signals in real time, significantly improving testing accuracy and efficiency. This technology ensures strict control at every link in the food supply chain, enabling fast early warnings that effectively prevent infections and provide robust protection for consumer health and public safety.
In agriculture and ecosystems, animals and plants are frequently threatened by bacteria, viruses, and fungi — such as African Swine Fever and crop wilt disease. Because early-stage infections often show few symptoms yet spread rapidly, delayed response can lead to severe economic losses and ecological disruption. Accurate detection is therefore the frontline defense against disease outbreaks. Compared to traditional methods that are time-intensive and require specialized equipment, the Bio-FET biochip offers a sensitive, rapid, Point-of-Care (POC) and field-deployable platform. It precisely detects DNA, RNA, or protein markers in tissue or bodily fluids, enabling early identification of low-concentration pathogens. This technology significantly enhances biosecurity response efficiency, providing strong support for agricultural productivity and ecological protection.
Our team is dedicated to the development and application of cutting-edge semiconductor biosensing technologies, providing end-to-end support from silicon hardware to complete system integration. In terms of chip supply, we provide a range of options including semiconductor bare dies, sensing components with specialized surface functionalization, and fully integrated Bio-FET biochips with universal cartridges. To support diverse detection needs, we also supply reader hardware and demonstration application prototypes, helping convert biological markers — such as DNA, RNA, or proteins — into high-sensitivity electronic signals. Our application scope spans clinical diagnostics, food safety, animal and plant disease prevention, and extends into environmental monitoring and biomedical research. We also leverage our deep technical expertise to provide troubleshooting consulting, ensuring detection systems achieve high accuracy, efficiency, and commercial viability.
The technology co-developed over many years by our team in collaboration with Professor Yu-Hsiung Yang at National Yang Ming Chiao Tung University was officially transferred and licensed on December 5, 2025, with ZhuMi Biotech assuming responsibility for its commercialization.